--- title: Latest News | Hemostemix (12) description: Company news for investors and health professionals (12) --- [![Hemostemix Logos](https://hemostemix.com/hubfs/Hemostemix%20Logos.png)](https://hemostemix.com) - [Patient Information](https://hemostemix.com/investigational-treatment-options) - [Physician Information](https://hemostemix.com/physicians) - ACP-01 Show submenu for ACP-01 - [ACP-01](https://hemostemix.com/acp-autologous-stem-cell-therapy) - [Clinical Research](https://hemostemix.com/clinical-research) - Conditions Show submenu for Conditions - [Cardiovascular Ischemia & Angina](https://hemostemix.com/cardiovascular-ischemia-angina) - [Chronic Limb Ischemia - CLTI](https://hemostemix.com/chronic-limb-threatening-ischemia) - [Peripheral Arterial Disease- PAD](https://hemostemix.com/peripheral-arterial-disease-pad-and-peripheral-ischemia) - [Vascular Dementia](https://hemostemix.com/vascular-dementia) - [Wound Care](https://hemostemix.com/wound-care) - Blog Show submenu for Blog - [Hemostemix Health Hub](https://hemostemix.com/health-hub-blog) - [Hemostemix Video Library](https://hemostemix.com/videolibrary) - [About](https://hemostemix.com/about) - [Patient Information](https://hemostemix.com/investigational-treatment-options) - [Physician Information](https://hemostemix.com/physicians) - ACP-01 Show submenu for ACP-01 - [ACP-01](https://hemostemix.com/acp-autologous-stem-cell-therapy) - [Clinical Research](https://hemostemix.com/clinical-research) - Conditions Show submenu for Conditions - [Cardiovascular Ischemia & Angina](https://hemostemix.com/cardiovascular-ischemia-angina) - [Chronic Limb Ischemia - CLTI](https://hemostemix.com/chronic-limb-threatening-ischemia) - [Peripheral Arterial Disease- PAD](https://hemostemix.com/peripheral-arterial-disease-pad-and-peripheral-ischemia) - [Vascular Dementia](https://hemostemix.com/vascular-dementia) - [Wound Care](https://hemostemix.com/wound-care) - Blog Show submenu for Blog - [Hemostemix Health Hub](https://hemostemix.com/health-hub-blog) - [Hemostemix Video Library](https://hemostemix.com/videolibrary) - [About](https://hemostemix.com/about) ![menu](https://f.hubspotusercontent40.net/hubfs/7479797/menu.png) ![close\_24px](https://7479797.fs1.hubspotusercontent-na1.net/hubfs/7479797/close_24px.svg) [Investor Site](https://investors.hemostemix.com/) ![](https://hemostemix.com/hubfs/Old%20Site%20Files/sublogo.png) ### Hemostemix All Post - [All Post](https://hemostemix.com/latest-news) - [Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations) - [Latest News](https://hemostemix.com/latest-news/tag/latest-news) - [Chronic Limb Threatening Ischemia](https://hemostemix.com/latest-news/tag/chronic-limb-threatening-ischemia) - [Uncategorized](https://hemostemix.com/latest-news/tag/uncategorized) - [Angina](https://hemostemix.com/latest-news/tag/angina) - [Stem Cells](https://hemostemix.com/latest-news/tag/stem-cells) - [Vascular Dementia](https://hemostemix.com/latest-news/tag/vascular-dementia) - Wound Care Search ###### [Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio](https://hemostemix.com/latest-news/hemostemix-engages-patentvest-to-strengthen-its-global-patent-portfolio) [Read More](https://hemostemix.com/latest-news/hemostemix-engages-patentvest-to-strengthen-its-global-patent-portfolio) ###### [HEMOSTEMIX ANNOUNCES ACP-01 TREATMENT-PURCHASE AVAILABLE WITH SOCIAL MEDIA CAMPAIGN UNDERWAY](https://hemostemix.com/latest-news/hemostemix-announces-acp-01-treatment-purchase-available-with-social-media-campaign-underway) [Read More](https://hemostemix.com/latest-news/hemostemix-announces-acp-01-treatment-purchase-available-with-social-media-campaign-underway) ###### [Hemostemix Announces the Incorporation of PreCerv Inc. and a Global Field of Use License to NCP-01](https://hemostemix.com/latest-news/hemostemix-announces-the-incorporation-of-precerv-inc-and-a-global-field-of-use-license-to-ncp-01) [Read More](https://hemostemix.com/latest-news/hemostemix-announces-the-incorporation-of-precerv-inc-and-a-global-field-of-use-license-to-ncp-01) [Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations) ###### [Hemostemix Announces the Incorporation of Hemostemix PR Inc: 50% reimbursement of R&D expenses in cash](https://hemostemix.com/latest-news/hemostemix-announces-the-incorporation-of-hemostemix-pr-inc-50-reimbursement-of-rd-expenses-in-cash) [Read More](https://hemostemix.com/latest-news/hemostemix-announces-the-incorporation-of-hemostemix-pr-inc-50-reimbursement-of-rd-expenses-in-cash) [Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations) ###### [Hemostemix Presents at Puerto Rico Investor Summits: Showcasing Global Scale-Up Strategy and Economic Impact](https://hemostemix.com/latest-news/hemostemix-presents-at-puerto-rico-investor-summits-showcasing-global-scale-up-strategy-and-economic-impact) [Read More](https://hemostemix.com/latest-news/hemostemix-presents-at-puerto-rico-investor-summits-showcasing-global-scale-up-strategy-and-economic-impact) [Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations) ###### [Hemostemix Announces First Sales Orders for ACP-01](https://hemostemix.com/latest-news/hemostemix-announces-first-sales-orders-for-acp-01) [Read More](https://hemostemix.com/latest-news/hemostemix-announces-first-sales-orders-for-acp-01) [8](https://hemostemix.com/latest-news/author/admin/page/8) [9](https://hemostemix.com/latest-news/author/admin/page/9) [10](https://hemostemix.com/latest-news/author/admin/page/10) [11](https://hemostemix.com/latest-news/author/admin/page/11) [12](https://hemostemix.com/latest-news/author/admin/page/12) [![LOGO\_Primary](https://hemostemix.com/hubfs/LOGO_Primary.png)](https://hemostemix.com) Leave us a message Follow Us Copyright © 2026 Hemostemix, Inc [Privacy Policy |](https://hemostemix.com/privacy-policy) [Terms of Service](https://hemostemix.com/sms-terms-of-service)